Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia

• Published in: Journal of lipid research Vol. 39; no. 5; pp. 1071 - 1078
• Main Authors: Bruce, C, Sharp, D S, Tall, A R
• Format: Journal Article
• Language: English
• Published: United States Elsevier 01-05-1998
• Subjects: Amino Acids - genetics; Amino Acids - metabolism; Carrier Proteins - genetics; Carrier Proteins - metabolism; Cholesterol Ester Transfer Proteins; Cholesterol Esters - metabolism; Cholesterol, HDL - metabolism; cholesteryl ester transfer protein; Coronary Disease - epidemiology; Coronary Disease - genetics; Coronary Disease - metabolism; coronary heart disease; Gene Frequency; Glycoproteins; high density lipoproteins; Humans; Hypertriglyceridemia - complications; Hypertriglyceridemia - genetics; Hypertriglyceridemia - metabolism; hypertryiglyceridemia; lipid transfer protein; Lipoproteins, HDL - physiology; Male; Polymorphism, Genetic; Prevalence
• ISSN: 0022-2275
• DOI: 10.1016/S0022-2275(20)33876-1

Plasma triglyceride (TG) levels are inversely related to HDL-cholesterol levels and subjects with high TG and low HDL cholesterol have increased coronary heart disease (CHD) risk. Plasma cholesteryl ester transfer protein (CETP) transfers cholesteryl esters from HDL to TG-rich lipoproteins. In this study we determined the relationship between a common CETP amino acid polymorphism (I405V) and CETP and HDL levels and CHD prevalence in 576 men of Japanese ancestry in the Honolulu Heart Program cohort. This conservative substitution was associated with altered plasma CETP concentration (1.95 +/- 0.54, 1.91 +/- 0.57, and 1.77 +/- 0.57 microg/ml for the II, IV and VV genotypes, respectively). The distribution of plasma CETP concentrations among the VV, but not II, men appeared bimodal (P < 0.01), suggesting the presence of a functionally significant CETP gene mutation(s) in a subset of V alleles. HDL-C levels were higher in VV than IV for II men (55.4 +/- 17.4, 51.3 +/- 16.6, 51.1 +/- 17.0 mg/dl, P < 0.04). However, the increase in HDL was only significant in VV men with plasma TG > 165 mg/dl. Although CHD prevalence was not significantly different among the three genotypes in this population, in the subpopulation with high plasma TG, CHD prevalence appeared higher among VV than IV or II subjects (38% vs. 27% vs. 18%, P < 0.05 for an interaction of genotype and plasma TG levels). In fresh plasma from a separate group of normolipidemic subjects, the V/I polymorphism was not associated with any change in plasma CETP specific activity. The data suggest that a widespread and common CETP gene mutation(s) in linkage disequilibrium with 405V causes low CETP. Among hypertriglyceridemic men this is associated with higher HDL and possibly with increased CHD.